» Articles » PMID: 36558529

Increased Thoracic Fluid As the Most Distinctive Cardiovascular Hemodynamic Alteration in Men with Prolactinoma

Overview
Journal Nutrients
Date 2022 Dec 23
PMID 36558529
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperprolactinemia in males with prolactin-secreting adenomas, or prolactinomas, may be associated with endothelial dysfunction and co-existing cardiovascular risk factors. As a noninvasive technique of assessing cardiac function, impedance cardiography (ICG) may be useful in the early detection of hemodynamic dysfunction. The aim of the present study was to analyze and compare the hemodynamic profiles of patients with prolactinoma versus controls. A total of 20 men with prolactinoma (PR group) (mean age 43 years) and 20 men from the control group (CG) were evaluated in this prospective, observational comparative clinical study. The study subjects were propensity score-matched in terms of clinical characteristics—age, mean blood pressure [MBP], arterial hypertension [AH] rates, and body mass index [BMI]. ICG assessments of hemodynamic profiles were conducted with the use of a Niccomo™ device and included stroke volume index (SI), cardiac index (CI), systemic vascular resistance index (SVRI), velocity index (VI), acceleration index (ACI), Heather index (HI), and thoracic fluid content (TFC). AH was well-controlled in both study groups (116/76 mmHg PR vs. 119/76 mmHg CG). In comparison with CG patients, ICG revealed PR group patients to have higher rates of high thoracic fluid content (TFC) (>35 1/kOhm; p = 0.035) and lower SI values (<35 mL/m2, p = 0.072). There was a convergent tendency towards lower values of other cardiac function parameters (SI, CI, VI, ACI, and HI). Prolactinoma-associated endocrine abnormalities are related to hemodynamic profile alterations, including higher rates of increased TFC and the risk of worsened cardiac function.

Citing Articles

Impaired cardiac pumping function and increased afterload as determinants of early hemodynamic alterations in Cushing disease.

Wlochacz A, Krzesinski P, Uzieblo-Zyczkowska B, Witek P, Zielinski G, Kazimierczak A Sci Rep. 2025; 15(1):233.

PMID: 39747547 PMC: 11696225. DOI: 10.1038/s41598-024-84888-x.


Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Dzialach L, Sobolewska J, Zak Z, Respondek W, Witek P Front Endocrinol (Lausanne). 2024; 15:1338345.

PMID: 38370355 PMC: 10870150. DOI: 10.3389/fendo.2024.1338345.


Effect of cardiac function in patients with gastrointestinal cancer with or without acute kidney injury assessed using a non-invasive impedance cardiography: a case-control study.

Chen H, Zhang G, He L, Zhou W, Zhang S, Niu Z BMC Cardiovasc Disord. 2023; 23(1):490.

PMID: 37794340 PMC: 10552419. DOI: 10.1186/s12872-023-03533-z.

References
1.
Strobeck J, Silver M . Beyond the four quadrants: the critical and emerging role of impedance cardiography in heart failure. Congest Heart Fail. 2004; 10(2 Suppl 2):1-6. DOI: 10.1111/j.1527-5299.2004.03405.x. View

2.
Reuwer A, Sondermeijer B, Battjes S, van Zijderveld R, Stuijver D, Bisschop P . Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study. Pituitary. 2011; 15(4):472-81. PMC: 3493673. DOI: 10.1007/s11102-011-0353-9. View

3.
Jurek A, Krzesinski P, Gielerak G, Witek P, Zielinski G, Kazimierczak A . Acromegaly: The Research and Practical Value of Noninvasive Hemodynamic Assessments Impedance Cardiography. Front Endocrinol (Lausanne). 2022; 12:793280. PMC: 8805171. DOI: 10.3389/fendo.2021.793280. View

4.
Reuwer A, van Zaane B, van Wissen M, van Zanten A, Twickler M, Gerdes V . Prolactin is involved in the systemic inflammatory response in myocardial infarction. Horm Metab Res. 2010; 43(1):62-5. DOI: 10.1055/s-0030-1265221. View

5.
Gruppetta M, Mercieca C, Vassallo J . Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2012; 16(4):545-53. DOI: 10.1007/s11102-012-0454-0. View